← Eichor
Study identifier: NCT05573828 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Usefulness of ICG Angiography-Guided Thyroidectomy for Preserving Parathyroid Function

Condition: Iatrogenic Hypocalcemia  ·  Sponsor: Hospital Universitari de Bellvitge

PhaseNA
Planned participants394
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersYes

About this study

Transient and/or permanent hypoparathyroidism is the most frequent complication after total thyroidectomy. The identification of the parathyroid glands and a correct dissection during thyroidectomy have been postulated as key factors for their preservation and, consequently, to prevent hypoparathyroidism. The use of indocyanine green (ICG) fluorescence has reliably predicted parathyroid glands functionality in the immediate postoperative period. Recently, it is proposed that showing the vascular map of the parathyroid glands before performing the thyroidectomy by means of ICG angiography prevent the development of postoperative hypoparathyroidism. The goal of this multicentric study is to demonstrate that the preservation of the function of parathyroid glands is greater with use of arteriography than without. Patients will be divided in two groups. In the study group, the vascular map with ICG of parathyroid glands will be showed before performing the lobectomy. Once the lobectomy is done, the function of the glands will be assessed. Whereas in the control group, arteriography with ICG will only be carried out in order to check their function at the end of the lobectomy. Researchers will compare the study group and the control group to see which one present the lowest taxes of postoperative hypoparathyroidism.

This description comes directly from the study's public registry record.

Talk to the study team

Pablo Moreno  ·  661214772  ·  25108pml@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Hospital UIniversitari de BellvitgeL'Hospitalet de Llobregat, Barcelona, SpainRecruiting
Pablo Moreno LlorenteL'Hospitalet de Llobregat, Barcelona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05573828